Analyst Consensus ?
ConsensusBuy28 ratings
Bullish1967.9%
Neutral932.1%
Bearish00.0%
AMETEK, Inc. · AME · FY2026 Q1 · Calendar Q2 2026
AMETEK Q1 2026: Record Orders, Raised Guidance, Defense MRO Expansion
AMETEK's Q1 FY2026 results reflect broad-based strength, with double-digit organic sales growth, record orders of $2.2 billion, and EBITDA of $620 million. EPS of $1.97 beat the $1.90 consensus by 3.68%, and revenue of $1.93 billion topped estimates by 0.73%. The company raised full-year EPS guidance to $7.94-$8.14 and completed the First Aviation Services acquisition to expand defense MRO capabilities. Management tone was confident, citing robust demand across defense, power, semiconductor, and space markets. The stock rose 3.35% on the report but drifted 4.10% lower subsequently. Prior-quarter comparative analysis was not available.
Reported Before market openNYSEIndustrials
$55.34B market cap
90quality score
Company context
Snapshot as of publicationAMETEK, Inc. is a global enterprise that develops and markets a diverse portfolio of electronic instruments and electromechanical devices. The company's operations are structured into two principal divisions: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). The EIG segment provides sophisticated instrumentation solutions catering to various sectors, including process control, aerospace, power generation, and general industrial applications. It also delivers specialized process and analytical tools essential for industries such as oil and gas, petrochemicals, pharmaceuticals, semiconductors, automation, and food and beverage production. Furthermore, EIG supplies equipment for laboratory settings, ultra-precision manufacturing, medical diagnostics, and critical test and measurement tasks.…
Earnings scorecard
Reported versus consensus
Reported EPS
$1.97
Consensus $2
EPS surprise
+3.7%
Reported versus consensus
Reported revenue
$1.93B
Consensus $1.91B
Revenue surprise
+0.7%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$235.25Current
$135Low
$225.31Average
$303High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 2, 2026 |
| DA Davidson | Buy | Buy | Maintain | May 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 4, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 1, 2026 |
| Baird | Neutral | Neutral | Maintain | Mar 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 27, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Feb 4, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 27, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jan 5, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Dec 23, 2025 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 16, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 2, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Feb 23, 2023 |
| Loop Capital | Buy | Buy | Maintain | Jul 19, 2022 |
| Rosenblatt | Buy | Buy | Maintain | Aug 4, 2021 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 12, 2020 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 7, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 11, 2019 |
| Jefferies | Buy | Buy | Maintain | Oct 13, 2017 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Feb 15, 2017 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 5, 2016 |
| Stifel | Buy | Buy | Maintain | Aug 5, 2016 |
| Citigroup | Buy | Neutral | Upgrade | May 8, 2013 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 7, 2013 |
| UBS | Neutral | Neutral | Maintain | Oct 31, 2012 |
| Ladenburg Thalmann | Buy | Hold | Upgrade | Jul 24, 2012 |
| Langenberg & Company | Hold | Buy | Downgrade | Apr 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $235.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $245 | $234.99 | +4.1% | Jul 10, 2026 |
| Truist Financial | Jamie Cook | $303 | $237.13 | +28.8% | Jul 2, 2026 |
| Redburn Partners | Richard Radbourne | $265 | $231.27 | +12.6% | Jun 18, 2026 |
| Truist Financial | Analyst unavailable | $275 | $231.3 | +16.9% | May 4, 2026 |
| Barclays | Julian Mitchell | $230 | $230.48 | -2.2% | May 4, 2026 |
| Robert W. Baird | Quinn Fredrickson | $244 | $231.98 | +3.7% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $270 | $232.62 | +14.8% | May 1, 2026 |
| BMO Capital | Daniel DiCicco | $253 | $211.47 | +7.5% | Mar 26, 2026 |
| Robert W. Baird | Analyst unavailable | $245 | $227.83 | +4.1% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $265 | $229.46 | +12.6% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $257 | $227.97 | +9.2% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $235 | $228.92 | -0.1% | Feb 4, 2026 |
| Barclays | Julian Mitchell | $220 | $228.92 | -6.5% | Feb 4, 2026 |
| Deutsche Bank | Analyst unavailable | $271 | $213.14 | +15.2% | Jan 21, 2026 |
| Morgan Stanley | Christopher Snyder | $215 | $211.1 | -8.6% | Jan 12, 2026 |
| Barclays | Julian Mitchell | $210 | $214.16 | -10.7% | Jan 7, 2026 |
| KeyBanc | Analyst unavailable | $235 | $211.31 | -0.1% | Jan 6, 2026 |
| Melius Research | Rob Wertheimer | $235 | $212.09 | -0.1% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $230 | $209.14 | -2.2% | Jan 5, 2026 |
| D.A. Davidson | Analyst unavailable | $240 | $199.92 | +2.0% | Dec 8, 2025 |
| Robert W. Baird | Richard Eastman | $204 | $202.11 | -13.3% | Nov 3, 2025 |
| Seaport Global | Analyst unavailable | $240 | $199.96 | +2.0% | Oct 31, 2025 |
| RBC Capital | Deane Dray | $229 | $198.84 | -2.7% | Oct 31, 2025 |
| KeyBanc | Analyst unavailable | $220 | $198.32 | -6.5% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $205 | $198.32 | -12.9% | Oct 31, 2025 |
| Truist Financial | Jamie Cook | $229 | $181.42 | -2.7% | Oct 8, 2025 |
| Mizuho Securities | Brett Linzey | $212 | $182.75 | -9.9% | May 16, 2025 |
| Truist Financial | Jamie Cook | $219 | $166.92 | -6.9% | Oct 9, 2024 |
| Oppenheimer | Christopher Glynn | $190 | $163.9 | -19.2% | Sep 10, 2024 |
| Seaport Global | Scott Graham | $200 | $154 | -15.0% | Aug 2, 2024 |
| Truist Financial | Jamie Cook | $204 | $165.57 | -13.3% | Jul 2, 2024 |
| Oppenheimer | Christopher Glynn | $200 | $169.13 | -15.0% | May 22, 2024 |
| Seaport Global | Scott Graham | $208 | $168.06 | -11.6% | May 6, 2024 |
| Robert W. Baird | Richard Eastman | $171 | $166.56 | -27.3% | May 6, 2024 |
| RBC Capital | Deane Dray | $216 | $179.34 | -8.2% | Apr 4, 2024 |
| Truist Financial | Jamie Cook | $210 | $181.53 | -10.7% | Mar 13, 2024 |
| Morgan Stanley | Analyst unavailable | $152 | $142.36 | -35.4% | Jan 6, 2023 |
| Mizuho Securities | Brett Linzey | $140 | $129.31 | -40.5% | Aug 15, 2022 |
| Morgan Stanley | Analyst unavailable | $145 | $126.04 | -38.4% | Aug 3, 2022 |
| RBC Capital | Analyst unavailable | $135 | $125.85 | -42.6% | Aug 3, 2022 |
| Loop Capital Markets | Analyst unavailable | $155 | $109.1 | -34.1% | Jul 19, 2022 |
| Mizuho Securities | Analyst unavailable | $135 | $110.92 | -42.6% | Jul 18, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $135 | $121.86 | -42.6% | Jun 3, 2022 |
| Morgan Stanley | Analyst unavailable | $144 | $124.06 | -38.8% | May 4, 2022 |
| RBC Capital | Analyst unavailable | $148 | $124.31 | -37.1% | May 4, 2022 |
| KeyBanc | Steve Barger | $145 | $124.31 | -38.4% | May 4, 2022 |
| D.A. Davidson | Matt Summerville | $160 | $138.12 | -32.0% | Aug 3, 2021 |
Track every rating change on AME the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session close
Stock move
+3.3%
Event window
SPY move
+1.0%
Same window
Abnormal move
+2.4%
Stock minus SPY
Volume
3.3×
Versus trailing sessions
Subsequent drift
-4.1%
Up to 20 sessions
AMESPY benchmark
Follow AME with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q1 FY2026 brought several records: orders of $2.2 billion, EBITDA of $620 million, and core margins of 27.9% (up 160 bps). AMETEK closed the First Aviation Services acquisition, disclosed its components on NASA's Artemis 2 mission, and posted free cash flow conversion of 107%. The stock rose 3.35% on the report with 3.25x normal volume, then drifted 4.10% lower.
Guidance delta
Full-year FY2026 EPS guidance was raised to $7.94-$8.14, reflecting strong Q1 performance. Capex outlook is stable. The company plans an incremental $100 million in R&D and sales/marketing investment for 2026.
Key takeaways
- Double-digit organic sales growth driven by defense, power, semiconductor, and space markets.
- Core margins expanded 160 basis points to 27.9%; EBITDA margin reached 32.1%.
- Full-year EPS guidance raised to $7.94-$8.14, reflecting strong Q1 performance.
- M&A remains top capital deployment priority with $5 billion of financial capacity; First Aviation Services deal closed.
- Free cash flow conversion of 107% supports continued dividend growth and share buybacks.
Management priorities
- Integrate First Aviation Services to expand defense MRO capabilities.
- Invest an incremental $100 million in R&D and sales/marketing for 2026.
- Launch the enhanced RTDS simulator platform with new data-center module.
- Continue pursuing bolt-on acquisitions within the $5 billion capital capacity.
- Maintain dividend growth and opportunistic share buybacks.
Related earnings events
IndustrialsURI · FY2026 Q2 · Calendar Q3 2026United Rentals Q2: Record Revenue, Raised Guidance, and a Possible Investment-Grade UpgradeNSC · FY2026 Q2 · Calendar Q3 2026Norfolk Southern Beats on Volume Strength as Intermodal and Coal Drive Q2 GrowthHON · FY2026 Q2 · Calendar Q3 2026Honeywell Q2: Beat and Raise as Portfolio Reshaping Nears Completion
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T20:02:15.776608+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T20:02:15.773723+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.